Literature DB >> 19332165

Usefulness of bone resorption markers in hemodialysis patients.

Takayuki Hamano1, Kodo Tomida, Satoshi Mikami, Isao Matsui, Naohiko Fujii, Enyu Imai, Hiromi Rakugi, Yoshitaka Isaka.   

Abstract

Although bone biopsy is a golden standard in the diagnosis of renal osteodystrophy, it is invasive and repetitive evaluation of bone status by this method is practically impossible. Non-invasive evaluation by bone metabolic markers such as serum cross-linked N-telopeptide of type I collagen (NTX) might give us additional information which cannot be obtained only by measurements of parathyroid hormone (PTH). These days, bone resorption marker, serum tartrate-resistant acid phosphatase (TRAP5b) was reported to be correlated with histomorphometric parameters of bone resorption in a bone biopsy study enrolling hemodialysis (HD) patients. In the current study, we studied the correlation of sera NTX and TRAP5b with bone mineral density (BMD) of second metacarpal bone in 103 HD patients and serial changes of these markers just after parathyroidectomy (PTX). Sera NTX and TRAP5b showed a significant positive relationship (R=0.79 P<0.0001). Simple regression analyses showed that both markers were significantly associated with BMD Z-score, whereas 1-84 PTH showed no significant association at all. This result might be attributed to diverse difference among HD patients in skeletal sensitivity to endogenous PTH. In fact, the ratios of TRAP5b/PTH and NTX/PTH denoting PTH sensitivity were significantly higher in postmenopausal female than male patients. Female gender, hemodialysis vintage, and log(PTH) were found to be significant positive determinants of serum log(TRAP5b) by multiple linear regression analysis. Receiver operating curve analysis for young adult mean 70% revealed that sensitivity was more than 95% when the cut-off value was set at 56.5 nmol BCE/L and 340 mU/L, but the specificity was only 29.5% and 34.4% for NTX and TRAP5b, respectively. Multiple regression analysis revealed that both markers were independent determinants of Z-score in two models including respective marker. Serial changes of both markers after PTX in 2 HD patients were comparable with gradual decrease of these markers. However, the reduction was sooner and larger in serum NTX. This sooner reduction might be attributed to the difference in characteristics of these markers regarding the effect of single HD session. Whereas serum NTX decreased, TRAP5b increased significantly after single session. Taken together, both markers give us additional information that cannot be obtained just by using PTH, provided that we know the characteristics of these markers.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19332165     DOI: 10.1016/j.bone.2009.03.663

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  5 in total

Review 1.  Evaluation of fracture risk in chronic kidney disease.

Authors:  Pablo Antonio Ureña Torres; Martine Cohen-Solal
Journal:  J Nephrol       Date:  2017-04-06       Impact factor: 3.902

2.  Predictors of osteoclast activity in patients with sickle cell disease.

Authors:  Mehdi Nouraie; Kevin Cheng; Xiaomei Niu; Evadne Moore-King; Margaret F Fadojutimi-Akinsi; Caterina P Minniti; Craig Sable; Sohail Rana; Niti Dham; Andrew Campbell; Gregory Ensing; Gregory J Kato; Mark T Gladwin; Oswaldo L Castro; Victor R Gordeuk
Journal:  Haematologica       Date:  2011-05-05       Impact factor: 9.941

3.  Effects of raloxifene on bone metabolism in postmenopausal women on chronic hemodialysis.

Authors:  Katsuyuki Nagatoya; Kazuhiko Nishimoto; Nobuhisa Shibahara; Toshikazu Takahashi; Hironori Kanehara; Nobuyuki Ueno; Hideaki Yasuda; Shigeki Okada; Haruhiko Ueda; Kei Hirai; Toru Inoue
Journal:  Clin Exp Nephrol       Date:  2014-12-11       Impact factor: 2.801

4.  Effects of cinacalcet on bone mineral density and bone markers in hemodialysis patients with secondary hyperparathyroidism.

Authors:  Yuki Tsuruta; Kazuhiro Okano; Kan Kikuchi; Yukio Tsuruta; Takashi Akiba; Kosaku Nitta
Journal:  Clin Exp Nephrol       Date:  2012-07-26       Impact factor: 2.801

5.  Serum sclerostin levels are positively related to bone mineral density in peritoneal dialysis patients: a cross-sectional study.

Authors:  Te-Hui Kuo; Wei-Hung Lin; Jo-Yen Chao; An-Bang Wu; Chin-Chung Tseng; Yu-Tzu Chang; Hung-Hsiang Liou; Ming-Cheng Wang
Journal:  BMC Nephrol       Date:  2019-07-17       Impact factor: 2.388

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.